• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-134-3p 通过靶向体外的 flap 结构特异性内切酶 1 抑制卵巢癌细胞的进展。

MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro.

机构信息

School of Minerals Processing and Bioengineering, Central South University, Changsha, Hunan 410083, P.R. China.

Department of Obstetrics and Gynecology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.

出版信息

Oncol Rep. 2021 Jan;45(1):119-128. doi: 10.3892/or.2020.7844. Epub 2020 Nov 10.

DOI:10.3892/or.2020.7844
PMID:33169800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7709829/
Abstract

Ovarian cancer (OC) is one of the most lethal gynecological malignancies in the world. The aim of the present study was to examine the role of microRNA (miR)-134-3p in OC. Reverse transcription-quantitative PCR was used to measure the expression levels of miR-134-3p. Cell Counting Kit-8, TUNEL, flow cytometric and colony formation assays were performed to examine the effects of miR-134-3p on OC cell proliferation. Moreover, wound healing and Transwell assays were performed to examine the effects on migration and invasion. In addition, western blot analyses were used to assess protein expression. Finally, the target genes of miR-134-3p were analyzed by bioinformatics analysis and dual-luciferase reporter assay. The results revealed that miR-134-3p expression was low in OC cells compared with in normal ovarian cells. The overexpression of miR-134-3p decreased cell viability, facilitated cell apoptosis, inhibited cell proliferation and arrested the cell cycle in SKOV-3 and OVCAR-3 cells. Furthermore, transfection using a miR-134-3p mimic inhibited the migration and invasion of SKOV-3 and OVCAR-3 cells, and decreased the protein expression levels of cyclooxygenase-2, matrix metalloproteinase (MMP)2 and MMP9. Bioinformatics analysis indicated that one of the potential target genes of miR-134-3p was flap structure-specific endonuclease 1 (FEN1), which was confirmed by dual-luciferase reporter assay. Moreover, overexpression of miR-134-3p decreased the expression levels of FEN1 in SKOV-3 and OVCAR-3 cells. Additionally, overexpression of FEN1 reversed the effects of the miR-134-3p mimic on the proliferation, migration and invasion of SKOV-3 and OVCAR-3 cells. Overall, the findings of the present study demonstrated that miR-134-3p may inhibit OC cell proliferation, migration and invasion by directly targeting FEN1.

摘要

卵巢癌(OC)是世界上最致命的妇科恶性肿瘤之一。本研究旨在探讨 microRNA(miR)-134-3p 在 OC 中的作用。逆转录定量 PCR 用于测量 miR-134-3p 的表达水平。细胞计数试剂盒-8、TUNEL、流式细胞术和集落形成实验用于检测 miR-134-3p 对 OC 细胞增殖的影响。此外,进行划痕愈合和 Transwell 实验以检测迁移和侵袭的影响。还使用 Western blot 分析来评估蛋白表达。最后,通过生物信息学分析和双荧光素酶报告基因实验分析 miR-134-3p 的靶基因。结果显示,与正常卵巢细胞相比,OC 细胞中 miR-134-3p 的表达较低。miR-134-3p 的过表达降低了 SKOV-3 和 OVCAR-3 细胞的活力,促进了细胞凋亡,抑制了细胞增殖并使细胞周期停滞。此外,miR-134-3p 模拟物的转染抑制了 SKOV-3 和 OVCAR-3 细胞的迁移和侵袭,并降低了环氧合酶-2、基质金属蛋白酶(MMP)2 和 MMP9 的蛋白表达水平。生物信息学分析表明,miR-134-3p 的一个潜在靶基因是 flap structure-specific endonuclease 1(FEN1),这通过双荧光素酶报告基因实验得到了证实。此外,miR-134-3p 的过表达降低了 SKOV-3 和 OVCAR-3 细胞中 FEN1 的表达水平。此外,FEN1 的过表达逆转了 miR-134-3p 模拟物对 SKOV-3 和 OVCAR-3 细胞增殖、迁移和侵袭的影响。综上所述,本研究结果表明,miR-134-3p 可能通过直接靶向 FEN1 抑制 OC 细胞的增殖、迁移和侵袭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/c639f8662bac/OR-45-01-0119-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/81ba2241c211/OR-45-01-0119-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/06e5c6e3c3b4/OR-45-01-0119-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/29364649ccbf/OR-45-01-0119-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/d181848775e3/OR-45-01-0119-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/c639f8662bac/OR-45-01-0119-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/81ba2241c211/OR-45-01-0119-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/06e5c6e3c3b4/OR-45-01-0119-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/29364649ccbf/OR-45-01-0119-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/d181848775e3/OR-45-01-0119-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/7709829/c639f8662bac/OR-45-01-0119-g04.jpg

相似文献

1
MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro.miRNA-134-3p 通过靶向体外的 flap 结构特异性内切酶 1 抑制卵巢癌细胞的进展。
Oncol Rep. 2021 Jan;45(1):119-128. doi: 10.3892/or.2020.7844. Epub 2020 Nov 10.
2
MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.miRNA-506-3p 通过靶向 SIRT1/AKT/FOXO3a 信号通路抑制卵巢癌细胞增殖并促进其凋亡。
Neoplasma. 2020 Mar;67(2):344-353. doi: 10.4149/neo_2020_190517N441. Epub 2020 Jan 21.
3
LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.长链非编码 RNA CASC9 通过细胞周期蛋白 G1/TP53/MMP7 信号通路促进卵巢癌细胞的增殖、转移和细胞周期进程。
Bioengineered. 2021 Dec;12(1):8006-8019. doi: 10.1080/21655979.2021.1981795.
4
Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30.miR-493-3p 的过表达通过下调 DPY30 抑制卵巢癌细胞增殖、迁移和侵袭。
Reprod Biol. 2022 Jun;22(2):100610. doi: 10.1016/j.repbio.2022.100610. Epub 2022 Mar 18.
5
MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer.在卵巢癌中,miR-5195-3p通过靶向RHBDD1发挥肿瘤抑制作用。
Histol Histopathol. 2023 Dec;38(12):1403-1413. doi: 10.14670/HH-18-595. Epub 2023 Feb 20.
6
MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.miR-574-3p 通过抑制 MMP3 表达在卵巢癌中发挥肿瘤抑制作用。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6839-6848. doi: 10.26355/eurrev_201908_18723.
7
Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.miR-302b-3p对N-乙酰葡糖胺基转移酶GCNT3的下调作用可降低非小细胞肺癌(NSCLC)细胞的增殖、迁移和侵袭能力。
Cell Physiol Biochem. 2018;50(3):987-1004. doi: 10.1159/000494482. Epub 2018 Oct 24.
8
MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.miR-29c-3p,LINC01296 的一个靶 miRNA,加速肿瘤恶性进展:LINC01296/miR-29c-3p 轴在卵巢癌中的治疗潜力。
J Ovarian Res. 2020 Mar 19;13(1):31. doi: 10.1186/s13048-020-00631-w.
9
microRNA-324-3p suppresses the aggressive ovarian cancer by targeting /RAS pathway.miRNA-324-3p 通过靶向/RAS 通路抑制侵袭性卵巢癌。
Bioengineered. 2022 May;13(5):12030-12044. doi: 10.1080/21655979.2022.2056314.
10
MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.微小 RNA miR-330-3p 通过靶向 RIPK4 抑制卵巢癌的进展。
Bioengineered. 2021 Dec;12(1):440-449. doi: 10.1080/21655979.2021.1871817.

引用本文的文献

1
Role of noncoding RNA as a pacemaker in cancer stem cell regulation: a review article.非编码RNA作为癌症干细胞调控起搏器的作用:一篇综述文章。
J Egypt Natl Canc Inst. 2025 Mar 24;37(1):9. doi: 10.1186/s43046-025-00266-2.
2
miR-134-3p Regulates Cell Proliferation and Apoptosis by Targeting INHBA via Inhibiting the TGF-β/PI3K/AKT Pathway in Sheep Granulosa Cells.miR-134-3p通过靶向抑制素βA(INHBA),抑制绵羊颗粒细胞中的TGF-β/PI3K/AKT信号通路,从而调控细胞增殖和凋亡。
Biology (Basel). 2024 Dec 30;14(1):24. doi: 10.3390/biology14010024.
3
Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1.
长链非编码 RNA PPP1R14B-AS1 通过上调 LIM 和 SH3 蛋白 1 模拟 microRNA-134-3p 促进乳腺癌进展。
Oncol Res. 2022 Aug 31;29(4):251-262. doi: 10.32604/or.2022.03582. eCollection 2021.
4
The influence of selected microRNAs on the expression profile of genes and proteins related to the tumor necrosis factor-alpha signaling pathways in endometrioid endometrial cancer.选定的 microRNAs 对子宫内膜样型子宫内膜癌中与肿瘤坏死因子-α信号通路相关的基因和蛋白质表达谱的影响。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9679-9689. doi: 10.1007/s00432-023-04863-3. Epub 2023 May 26.
5
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.卵巢癌中失调的miRNA簇:对个性化医疗的重要意义。
Genes Dis. 2022 Mar 1;9(6):1443-1465. doi: 10.1016/j.gendis.2021.12.026. eCollection 2022 Nov.
6
Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.非编码RNA在卵巢癌预后和治疗中的最新进展
Ther Adv Med Oncol. 2022 Aug 12;14:17588359221118010. doi: 10.1177/17588359221118010. eCollection 2022.
7
SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines.SOX9 是乳腺癌细胞系中 miR-134-3p 和 miR-224-3p 的靶标。
Mol Cell Biochem. 2023 Feb;478(2):305-315. doi: 10.1007/s11010-022-04507-z. Epub 2022 Jul 2.
8
miR-4324 inhibits ovarian cancer progression by targeting FEN1.miR-4324 通过靶向 FEN1 抑制卵巢癌进展。
J Ovarian Res. 2022 Mar 4;15(1):32. doi: 10.1186/s13048-022-00959-5.
9
The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma.FEN1在原发性骨肉瘤中表达的临床意义
Int J Gen Med. 2021 Oct 7;14:6477-6485. doi: 10.2147/IJGM.S335817. eCollection 2021.
10
LncRNA SNHG20 promotes cell proliferation and invasion by suppressing miR-217 in ovarian cancer.长链非编码 RNA SNHG20 通过抑制卵巢癌细胞中的 miR-217 促进细胞增殖和侵袭。
Genes Genomics. 2021 Sep;43(9):1095-1104. doi: 10.1007/s13258-021-01138-4. Epub 2021 Jul 24.